|
Case number
|
n
|
120
|
32
| | |
|
Age
|
Mean ± SD
|
51.89 ± 10.96
|
56.47 ± 11.36
|
150
|
0.039a
|
| |
Range
|
22–79
|
31–81
|
|
Gender
| | | |
1
|
0.844c
|
|
Male
|
n (%)
|
92 (76.7%)
|
24 (75.0%)
|
|
Female
|
n (%)
|
28 (23.3%)
|
8 (25.0%)
|
|
Period of pain (months)
|
n
|
86
|
17
|
–
|
0.098b
|
| |
Median (Interquartile range)
|
18 (12–26.5)
|
13 (5.5–24)
|
| |
Range
|
1–102
|
1–72
|
|
ADV total treatment time (months)
|
n
|
115
|
30
|
–
|
0.939b
|
| |
Median (Interquartile range)
|
60 (36–72)
|
57 (38–69)
|
| |
Range
|
5–144
|
9–132
|
|
ADV treatment time of pain onset (months)
|
n
|
87
|
22
|
–
|
0.153b
|
| |
Median (Interquartile range)
|
36 (24–48)
|
47.5 (28–60)
|
| |
Range
|
2–95
|
1–90
|
|
BMI (kg/m2)
|
n
|
8
|
5
|
11
|
0.192a
|
| |
Mean ± SD
|
21.21 ± 1.85
|
23.44 ± 3.98
|
| |
Range
|
19.53–24.70
|
18.00–28.00
|
|
Initial time of pain relief (months)
|
n
|
76
|
20
|
–
|
0.003b
|
| |
Median (Interquartile range)
|
1.5 (1–2)
|
3 (2–6)
|
| |
Range
|
0.3–6.0
|
0.5–18.0
|
|
Initial time of serum Phos. Rising (months)
|
n
|
53
|
11
|
–
|
0.115b
|
| |
Median (Interquartile range)
|
2 (1–3)
|
3.5 (1.75–6)
|
| |
Range
|
0.3–12.0
|
0.5–11.0
|
